These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9549959)

  • 1. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
    Alderman J; Wolkow R; Chung M; Johnston HF
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):386-94. PubMed ID: 9549959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    Rasmussen S; Hackett E; DuBoff E; Greist J; Halaris A; Koran LM; Liebowitz M; Lydiard RB; McElroy S; Mendels J; O'Connor K
    Int Clin Psychopharmacol; 1997 Nov; 12(6):309-16. PubMed ID: 9547132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response to sertraline in adolescents with obsessive-compulsive disorder].
    Rodríguez-Ramos P; Mardomingo Sanz MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):17-21. PubMed ID: 9549132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D; McTavish D
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH; Jefferson JW; Kobak KA; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowtiz MR; Lydiard B
    Int Clin Psychopharmacol; 1995 Jun; 10(2):57-65. PubMed ID: 7673657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug concentration monitoring with tolerability and efficacy assessments during open-label, long-term sertraline treatment of children and adolescents.
    Alderman J; Wolkow R; Fogel IM
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):117-29. PubMed ID: 16553533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    Chouinard G
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
    Greist J; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowitz M; Lydiard RB; Rasmussen S; White K
    Arch Gen Psychiatry; 1995 Apr; 52(4):289-95. PubMed ID: 7702445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
    JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
    Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline and mental retardation with obsessive-compulsive disorder.
    Wiener K; Lamberti JS
    Am J Psychiatry; 1993 Aug; 150(8):1270. PubMed ID: 8328577
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
    Zarate CA; Kando JC; Tohen M; Weiss MK; Cole JO
    J Clin Psychiatry; 1996 Feb; 57(2):67-71. PubMed ID: 8591971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.
    Tini E; Smigielski L; Romanos M; Wewetzer C; Karwautz A; Reitzle K; Correll CU; Plener PL; Malzahn U; Heuschmann P; Unterecker S; Scherf-Clavel M; Rock H; Antony G; Briegel W; Fleischhaker C; Banaschewski T; Hellenschmidt T; Imgart H; Kaess M; Kölch M; Renner T; Reuter-Dang SY; Rexroth C; Schulte-Körne G; Theisen F; Fekete S; Taurines R; Gerlach M; Egberts KM; Walitza S
    Compr Psychiatry; 2022 May; 115():152301. PubMed ID: 35248877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline in the treatment of neurotic excoriations and related disorders.
    Kalivas J; Kalivas L; Gilman D; Hayden CT
    Arch Dermatol; 1996 May; 132(5):589-90. PubMed ID: 8624163
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
    Dodt JE; Byerly MJ; Cuadros C; Christensen RC
    Am J Psychiatry; 1997 Apr; 154(4):582. PubMed ID: 9090357
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.
    Cook EH; Wagner KD; March JS; Biederman J; Landau P; Wolkow R; Messig M
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1175-81. PubMed ID: 11589530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
    Allen L; Tejera C
    Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
    Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.